End of an ERA: lessons from negative clinical trials in idiopathic pulmonary fibrosis
- PMID: 21737589
- DOI: 10.1164/rccm.201105-0813ED
End of an ERA: lessons from negative clinical trials in idiopathic pulmonary fibrosis
Comment on
-
BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis.Am J Respir Crit Care Med. 2011 Jul 1;184(1):92-9. doi: 10.1164/rccm.201011-1874OC. Epub 2011 Apr 7. Am J Respir Crit Care Med. 2011. PMID: 21474646 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
